Feinstein said on Thursday she had spoken “voluntarily” with FBI agents and handed over documents to indicate she had “no involvement” in her husband’s decision to sell off between $500,000 to $1 million in a biotech company, Allogene Therapeutics, this January.
The sale came shortly before the market tumbled due to the coronavirus pandemic. Feinstein’s admission came on the same day Sen. Richard Burr stepped down as chair of the Senate Intelligence Committee because of an ongoing investigation into his own unloading of stock in February.
Unlike Burr, who unloaded stock mainly in travel and hospitality companies that were hardest hit due to the coronavirus travel restrictions, Feinstein’s former shares in Allogene have since increased in value. It remains unclear if the DOJ has opened an investigation into Feinstein and her husband for the sale.